GlassScriptPhysician profile
Megan Toole
NPI 1184035172
$38,396.32
in general payments reported to CMS, 2019-2025
34 companies · $2,393 in 2025
The $2,393 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,825 · 2020: $375 · 2021: $1,187 · 2022: $23K · 2023: $5,367 · 2024: $4,279 · 2025: $2,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,167 · Travel and Lodging: $4,871 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,166.90 |
| Travel and Lodging | $4,870.99 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,635.67 | 2021-2025 | Corevalve Evolut R, Resolute Onyx, Micra |
| Edwards Lifesciences Corporation | $6,873.10 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Abiomed | $908.17 | 2019-2025 | Impella |
| Shockwave Medical, INC | $701.48 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $620.05 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $522.22 | 2019-2022 | |
| Abbott Laboratories | $493.82 | 2019-2025 | Amplatzer Amulet, Xience Skypoint, Jot Dx |
| Philips North America LLC | $488.68 | 2021-2024 | (9520) Igt Devices Undivided, (Cq1) Azurion 7 M20 Gc |
| Inari Medical, INC. | $365.96 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $280.41 | 2022-2025 | Avvigo Guidance System |
| Pfizer INC. | $279.09 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $231.54 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $217.89 | 2019-2022 | |
| Novo Nordisk INC | $160.03 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Irhythm Technologies, INC. | $149.20 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $140.24 | 2020 | |
| Livanova USA, INC. | $134.57 | 2022 | |
| Lantheus Medical Imaging, INC. | $130.95 | 2019 | |
| Teleflex LLC | $125.25 | 2023 | Manta |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Chiesi USA, INC. | $120.83 | 2023 | Kengreal, Cleviprex |
| Astellas Pharma US INC | $105.20 | 2019 | |
| Btg International INC. | $100.80 | 2019 | |
| Amgen INC. | $94.16 | 2019-2020 | |
| Braemar Manufacturing, LLC | $72.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $59.44 | 2019 | |
| Terumo Medical Corporation | $46.00 | 2020-2021 | |
| Akcea Therapeutics, INC. | $43.85 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $36.35 | 2019-2022 | |
| Gilead Sciences, INC. | $30.49 | 2019 | |
| Cardiva Medical, INC. | $28.99 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $27.48 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $27.17 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $19.44 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Toole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.